English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Anticoagulation therapy is routinely used in settings ranging from the emergency room to presurgery. Idaho Technology has developed genotyping reagents targeting three loci: alleles *2 and *3 in the CYP2C9 gene and c.1 G-1639A in VKORC1. With a rapid turnaround time of <1 hour or the ability to increase throughput using traditional 96- or 384-well plate format, these reagents are appropriate for a range of settings.

CYP2C9 and VKORC1 genotyping reagents from Idaho Technology: rapid turn-around, accurate results